Literature DB >> 21514484

Adherence and oral agents with older patients.

Kristen W Maloney1, Sarah H Kagan.   

Abstract

OBJECTIVE: Oral antineoplastic agents offer multiple advantages in cancer therapies. Thus, understanding issues of adherence to these agents for older adults becomes critical to successful comprehensive care of the older cancer patient. DATA SOURCES: This analysis of adherence to oral agents among older cancer patients draws on interdisciplinary geriatric and oncologic research reports and clinical reviews.
CONCLUSION: Older adults are at increased risk for poor adherence to oral agents. Barriers to adherence are diverse. Problems emerge from age-related physical changes, comorbid conditions, polypharmacy, and drug interactions. Psychosocial barriers include limited insurance coverage and transportation problems to social isolation and inadequate social support. IMPLICATION FOR NURSING PRACTICE: Nurses should lead interdisciplinary, individualized plans of care to mitigate barriers and support adherence to cancer therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514484     DOI: 10.1016/j.soncn.2011.02.007

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  4 in total

1.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

Review 2.  How to implement a geriatric assessment in your clinical practice.

Authors:  Schroder Sattar; Shabbir M H Alibhai; Hans Wildiers; Martine T E Puts
Journal:  Oncologist       Date:  2014-09-03

Review 3.  Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients.

Authors:  J Feliu; V Heredia-Soto; R Gironés; B Jiménez-Munarriz; J Saldaña; C Guillén-Ponce; M J Molina-Garrido
Journal:  Clin Transl Oncol       Date:  2019-06-25       Impact factor: 3.405

4.  An automated system for detecting nonadherence in laboratory testing and monitoring for myelosuppression in patients receiving self-administered oral chemotherapy.

Authors:  Robert M Morrell; Janet A Tooze; Michele S Harmon; Annette F Carter; Alisha T DeTroye; Glenn J Lesser
Journal:  J Oncol Pract       Date:  2013-05-07       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.